Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide

Key Takeaways89,592 bottles of children’s ibuprofen were recalledReports said that black particles and gel-like materials were found in some bottlesThe affected lot numbers include 7261973A and 7261974A.MONDAY, March 23, 2026 (HealthDay News) — Consumers who have children’s ibuprofen at home may want to check the label.Nearly 90,000 bottles have been recalled over possible contamination, the U.S. Food and Drug Administration (FDA) said.The recall affects 89,592 bottles of Children’s Ibuprofen Oral Suspension made by Strides Pharma for Taro Pharmaceuticals USA, Inc.The issue? Some bottles may contain a foreign substance.The FDA said complaints described “a gel-like mass and black particles” found inside the medicine.The recall affects Children’s Ibuprofen Oral Suspension, USP with:A strength of 100 mg per 5 mLA bottle size of 4 fluid ounces (120 mL)Affected lot numbers 7261973A and 7261974ABoth have an expiration date of Jan. 31, 2027, and they were distributed nationwide.The company initiated the recall March 2 after receiving complaints about the ibuprofen.The FDA has classified it as a Class II recall. That means using the product could cause temporary or medically reversible health problems, but the risk of serious harm is considered low.Health officials say families should stop using the recalled ibuprofen right away.No additional instructions, such as returns or refunds, were included in the FDA’s report, NBC News said.More informationThe Mayo Clinic has more on ibuprofen.SOURCE: NBC News, March 19, 2026.What This Means For YouThose with children’s ibuprofen at home should check the lot number and stop using it if it matches..Sign up for our weekly HealthDay newsletter

Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide

Related Stories

First Generic Combo Hormone Patch Could Make Menopause Relief More Affordable

FDA Patient, Consumer Reps Often Tied To Pharma-Funded Groups

Is Raw Milk Safe For Kids? Pediatricians Warn About The Risks

A Heart Valve That Grows Up With The Patient Wins FDA Approval